| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1464-5491.1994.TB00256.X |
| P698 | PubMed publication ID | 7895463 |
| P2093 | author name string | G S Meneilly | |
| K Dawson | |||
| D Tessier | |||
| J P Tétrault | |||
| G Bravo | |||
| P433 | issue | 10 | |
| P921 | main subject | gliclazide | Q290001 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 974-980 | |
| P577 | publication date | 1994-12-01 | |
| P1433 | published in | Diabetic Medicine | Q15758639 |
| P1476 | title | Glibenclamide vs gliclazide in type 2 diabetes of the elderly | |
| P478 | volume | 11 |
| Q77157492 | A short term cost-effectiveness model for oral antidiabetic medicines in Europe |
| Q44205053 | Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality |
| Q110453608 | Characterization of the SARS-CoV-2 E Protein: Sequence, Structure, Viroporin, and Inhibitors |
| Q71337406 | Diabetes mellitus in older patients. Is tight blood glucose control warranted? |
| Q64950502 | Diabetes mellitus in older persons. |
| Q41180424 | Drug-induced disorders of glucose metabolism. Mechanisms and management |
| Q78044125 | Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes |
| Q34739954 | Hypoglycaemia in Type 2 diabetes |
| Q34485028 | Hypoglycaemia in elderly diabetic patients. |
| Q38899869 | Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis. |
| Q36519973 | Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. |
| Q35073384 | Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines |
| Q51572069 | Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study. |
| Q41664462 | Non-insulin-dependent diabetes mellitus in the elderly |
| Q38213126 | Optimal utilisation of sulphonylureas in resource-constrained settings |
| Q33664745 | Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action |
| Q33713451 | Oral antihyperglycemic therapy for type 2 diabetes mellitus. |
| Q37101608 | Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study |
| Q27022613 | Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials |
| Q38577058 | Sulfonylureas and their use in clinical practice. |
| Q38137027 | The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis |
| Q34316689 | The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes |
| Q33821279 | The use of sulphonylureas in the elderly |
| Q36369818 | Use of antidiabetic drugs in elderly patients. |
| Q83178892 | [Diabetes Care Austria 2009: registry for type 2 diabetic patients in general practitioners' ordinations in Austria] |
Search more.